GlobeNewswire 12/15/2016 Aptevo Therapeutics Amends Collaboration Agreement with MorphoSys AG for Novel Immunotherapeutic, MO...
GlobeNewswire 12/13/2016 MorphoSys Starts Phase 2 Trial of MOR208 in Combination with Idelalisib in Patients with Relapsed or...
GlobeNewswire 12/13/2016 MorphoSys Starts Phase 2 Trial of MOR208 in Combination with Idelalisib in Patients with Relapsed or...
GlobeNewswire 12/6/2016 MorphoSys Presents Updated Clinical Results for Anti-CD38 Antibody MOR202 at ASH 2016
GlobeNewswire 12/6/2016 MorphoSys Presents Updated Clinical Data for Blood Cancer Candidate MOR208 in NHL and CLL at ASH 201...
GlobeNewswire 12/6/2016 MorphoSys Presents Updated Clinical Data for Blood Cancer Candidate MOR208 in NHL and CLL at ASH 201...
GlobeNewswire 12/6/2016 MorphoSys Presents Updated Clinical Results for Anti-CD38 Antibody MOR202 at ASH 2016
GlobeNewswire 11/29/2016 MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...
GlobeNewswire 11/28/2016 MorphoSys Announces That Its Licensee Janssen Has Submitted a Marketing Authorisation Application Fo...
GlobeNewswire 11/28/2016 MorphoSys Announces That Its Licensee Janssen Has Submitted a Marketing Authorisation Application Fo...
GlobeNewswire 11/25/2016 MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...
GlobeNewswire 11/22/2016 Correction of a release from 21.11.2016, 18:05 CET - MorphoSys AG: Publication pursuant to §26 sect....
GlobeNewswire 11/21/2016 MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...
GlobeNewswire 11/21/2016 MorphoSys AG: Notification of managers`transactions according to article 19 MAR
GlobeNewswire 11/21/2016 MorphoSys AG: Notification of managers`transactions according to article 19 MAR
GlobeNewswire 11/17/2016 MorphoSys Announces That Its Licensee Janssen Has Submitted Biologics License Application For Guselk...
GlobeNewswire 11/17/2016 MorphoSys Announces That Its Licensee Janssen Has Submitted Biologics License Application For Guselk...
GlobeNewswire 11/17/2016 MorphoSys AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim of...
GlobeNewswire 11/15/2016 MorphoSys Raises EUR 115 million in Private Placement
GlobeNewswire 11/15/2016 Ad hoc: MorphoSys Raises EUR 115 million in Private Placement
GlobeNewswire 11/15/2016 MorphoSys Raises EUR 115 million in Private Placement
GlobeNewswire 11/15/2016 Ad hoc: MorphoSys Raises EUR 115 million in Private Placement
GlobeNewswire 11/15/2016 Ad hoc: MorphoSys to Raise Capital via a Private Placement of New Shares
GlobeNewswire 11/15/2016 MorphoSys to Raise Capital via a Private Placement of New Shares
GlobeNewswire 11/15/2016 MorphoSys to Raise Capital via a Private Placement of New Shares